{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:33:04Z","timestamp":1788957184828,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ23H090004"],"award-info":[{"award-number":["LQ23H090004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jtauto.2023.100218","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T12:21:48Z","timestamp":1697113308000},"page":"100218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Anti-adenylate kinase 5 encephalitis: Clinical characteristics, diagnosis, and management of this rare entity"],"prefix":"10.1016","volume":"7","author":[{"given":"Er-Chuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Lun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ting","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-Li","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4462-171X","authenticated-orcid":false,"given":"Yin-Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2023.100218_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3949\/ccjm.88a.20122","article-title":"Antibody-mediated autoimmune encephalitis: a practical approach","volume":"88","author":"Abbatemarco","year":"2021","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.jtauto.2023.100218_bib2","article-title":"Editorial: antibody-mediated autoimmune diseases of the CNS: challenges and approaches to diagnosis and management","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jtauto.2023.100218_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib5","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/WNL.55.12.1823","article-title":"Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy","volume":"55","author":"Bien","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2023.100218_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2169\/internalmedicine.42.428","article-title":"Steroid-responsive limbic encephalitis","volume":"42","author":"Watanabe","year":"2003","journal-title":"Intern. Med."},{"key":"10.1016\/j.jtauto.2023.100218_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jneuroim.2007.03.015","article-title":"Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis","volume":"186","author":"T\u00fcz\u00fcn","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jtauto.2023.100218_bib8","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.autrev.2016.07.018","article-title":"From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time","volume":"15","author":"van Sonderen","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2023.100218_bib9","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/brain\/awab153","article-title":"Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis","volume":"144","author":"Mu\u00f1iz-Castrillo","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jtauto.2023.100218_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109074","article-title":"Kelch-like protein 11 antibody-associated paraneoplastic neurological syndrome: a state-of-the-art review","volume":"241","author":"Li","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jtauto.2023.100218_bib11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.0000000000003586","article-title":"Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies","volume":"88","author":"Do","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2023.100218_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.576975","article-title":"Identification of adenylate kinase 5 antibodies during routine diagnostics in a tissue-based assay: three new cases and a review of the literature","volume":"334","author":"Bien","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jtauto.2023.100218_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001010","article-title":"Anti-adenylate kinase 5 encephalitis with histologic evidence of CNS vasculitis","volume":"8","author":"Vicino","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jtauto.2023.100218_bib14","first-page":"299","article-title":"Anti-AK5 encephalitis: subacute anterograde amnesia is not the only clinical presentation","author":"Guillaume","year":"2022","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jtauto.2023.100218_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577861","article-title":"Adenylate kinase 5 (AK5) autoimmune encephalitis: clinical presentations and outcomes in three new patients","volume":"367","author":"McKeon-Makki","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jtauto.2023.100218_bib16","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00415-020-09782-8","article-title":"Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies","volume":"267","author":"Mu\u00f1iz-Castrillo","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92147-6","article-title":"Identification of novel DNA hypermethylation of the adenylate kinase 5 promoter in colorectal adenocarcinoma","volume":"11","author":"Ahn","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2023.100218_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jneuroim.2015.08.009","article-title":"Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitis","volume":"287","author":"Ng","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jtauto.2023.100218_bib19","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jtauto.2023.100218_bib20","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jtauto.2023.100218_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1750-3639.1993.tb00747.x","article-title":"Paraneoplasia and autoimmunologic injury of the nervous system: the anti-Hu syndrome","volume":"3","author":"Rosenblum","year":"1993","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jtauto.2023.100218_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: presentation and long-term outcome","volume":"87","author":"Ari\u00f1o","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2023.100218_bib23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib24","article-title":"Contemporary advances in anti-NMDAR antibody (Ab)-mediated encephalitis","volume":"21","author":"Seery","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2023.100218_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211003486","article-title":"GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions","volume":"14","author":"Tsiortou","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jtauto.2023.100218_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13760-021-01853-5","article-title":"Anti-AK5 encephalitis: subacute anterograde amnesia is not the only clinical presentation","volume":"123","author":"Guillaume","year":"2023","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jtauto.2023.100218_bib27","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2023.100218_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","article-title":"Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease","volume":"20","author":"Hermann","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp-2020-325302","article-title":"Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management","volume":"92","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jtauto.2023.100218_bib30","first-page":"467","article-title":"Limbic encephalitis, handb","volume":"187","author":"Bien","year":"2022","journal-title":"Clin. Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1793","article-title":"Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: a systematic review","volume":"10","author":"Ghimire","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.jtauto.2023.100218_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2023.100218_bib34","article-title":"Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor encephalitis: a review","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2023.100218_bib35","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib36","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jamaneurol.2020.2231","article-title":"Expanded clinical phenotype, oncological associations, and immunopathologic insights of paraneoplastic kelch-like protein-11 encephalitis","volume":"77","author":"Dubey","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMoa1816721","article-title":"Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis","volume":"381","author":"Mandel-Brehm","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2023.100218_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab185","article-title":"Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis","volume":"3","author":"Vogrig","year":"2021","journal-title":"Brain Commun"},{"key":"10.1016\/j.jtauto.2023.100218_bib39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ejpn.2015.06.005","article-title":"Anti-Ma2-encephalitis in a 2 year-old child: a newly diagnosed case and literature review","volume":"19","author":"Mrabet","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jtauto.2023.100218_bib41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jalm\/jfab127","article-title":"Clinical sensitivity, specificity, and predictive value of neural antibody testing for autoimmune encephalitis","volume":"7","author":"Budhram","year":"2022","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.jtauto.2023.100218_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12883-016-0657-5","article-title":"Intrathecal synthesis of anti-Hu antibodies distinguishes patients with paraneoplastic peripheral neuropathy and encephalitis","volume":"16","author":"Schwenkenbecher","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib43","article-title":"Anti-Hu antibodies activate enteric and sensory neurons","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2023.100218_bib44","doi-asserted-by":"crossref","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","article-title":"Encephalitis with mGluR5 antibodies: symptoms and antibody effects","volume":"90","author":"Spatola","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2023.100218_bib45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41582-020-0359-x","article-title":"GAD antibodies in neurological disorders - insights and challenges","volume":"16","author":"Graus","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib46","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Ari\u00f1o","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jtauto.2023.100218_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121364","article-title":"Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity","volume":"10","author":"Gresa-Arribas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2023.100218_bib48","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.3390\/ijms21103701","article-title":"Neurological syndromes associated with anti-GAD antibodies","volume":"21","author":"Dade","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258990902300031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258990902300031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:36:04Z","timestamp":1762904164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258990902300031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":48,"alternative-id":["S258990902300031X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2023.100218","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-adenylate kinase 5 encephalitis: Clinical characteristics, diagnosis, and management of this rare entity","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2023.100218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100218"}}